Back
ESC Professional Premium Access

Immunomodulatory effect of first-in-human PeriCord cardiac bioimplant: preliminary data of the PERISCOPE clinical trial

Session: Coronary artery disease - Treatment
Topic: Nonpharmacological Treatment
Speaker: Doctor M. Monguio-Tortajada (Badalona, ES)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Marta Monguio-Tortajada

Health Science Research Institute Germans Trias i Pujol, Badalona (Spain)
0 follower

4 more presentations in this session

Factors associated with early catheterization in patients randomized to the conservative strategy in the ISCHEMIA Trial

Speaker: Doctor R. Pracon (Warsaw, PL)

Access
Abstract
Slides
Like
Thumbnail

Impact of high intensity interval training on coronary atheromatous plaques evaluated by IVUS - a randomized trial

Speaker: Mrs E. Vesterbekkmo (Trondheim, NO)

Access
Abstract
Slides
Like
Thumbnail

Effect of supervised high-intensity interval training on haemostasis in patients with coronary artery disease: a randomised controlled trial

Speaker: Doctor J. Kristiansen (Aarhus N, DK)

Access
Abstract
Slides
Like
Thumbnail

Coronary sinus reducer device for the treatment of refractory angina therapy. A multicentric initial experience.

Speaker: Doctor C. Brizido (Carnaxide, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Coronary artery disease - Treatment

Speakers: Doctor M. Monguio-Tortajada, Doctor R. Pracon, Mrs E. Vesterbekkmo, Doctor J. Kristiansen, Doctor C. Brizido
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources